BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32707902)

  • 1. Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas.
    Turkowski K; Herzberg F; Günther S; Brunn D; Weigert A; Meister M; Muley T; Kriegsmann M; Schneider MA; Winter H; Thomas M; Grimminger F; Seeger W; Savai Pullamsetti S; Savai R
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
    Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
    Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRDM16 functions as a suppressor of lung adenocarcinoma metastasis.
    Fei LR; Huang WJ; Wang Y; Lei L; Li ZH; Zheng YW; Wang Z; Yang MQ; Liu CC; Xu HT
    J Exp Clin Cancer Res; 2019 Jan; 38(1):35. PubMed ID: 30683132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.
    Zhang Y; Wu X; Kai Y; Lee CH; Cheng F; Li Y; Zhuang Y; Ghaemmaghami J; Chuang KH; Liu Z; Meng Y; Keswani M; Gough NR; Wu X; Zhu W; Tzatsos A; Peng W; Seto E; Sotomayor EM; Zheng X
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
    Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
    Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma.
    Watt K; Newsted D; Voorand E; Gooding RJ; Majewski A; Truesdell P; Yao B; Tuschl T; Renwick N; Craig AW
    Cell Signal; 2018 Oct; 50():25-36. PubMed ID: 29935234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis.
    Jan YH; Lai TC; Yang CJ; Lin YF; Huang MS; Hsiao M
    J Hematol Oncol; 2019 Jan; 12(1):12. PubMed ID: 30696468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of low ADARB1 expression in lung adenocarcinoma.
    Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y
    PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer.
    Huang TH; Wu ATH; Cheng TS; Lin KT; Lai CJ; Hsieh HW; Chang PM; Wu CW; Huang CF; Chen KY
    J Cell Mol Med; 2019 Dec; 23(12):8184-8195. PubMed ID: 31638335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Xuan YW; Liao M; Zhai WL; Peng LJ; Tang Y
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8411-8421. PubMed ID: 31646571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein B8 promotes proliferation and migration in lung adenocarcinoma A549 cells by maintaining mitochondrial function.
    Yu LL; Wang Y; Xiao ZK; Chen SS
    Mol Cell Biochem; 2021 Jan; 476(1):187-197. PubMed ID: 32926297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.
    Qi L; Song W; Li L; Cao L; Yu Y; Song C; Wang Y; Zhang F; Li Y; Zhang B; Cao W
    Oncotarget; 2016 Nov; 7(45):74015-74030. PubMed ID: 27677589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)-182/miR-93-leukemia inhibitory factor receptor pathway.
    Wang L; Liang Y; Mao Q; Xia W; Chen B; Shen H; Xu L; Jiang F; Dong G
    Cancer Sci; 2019 Sep; 110(9):2960-2972. PubMed ID: 31301086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
    Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
    BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.